{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:25:06Z","timestamp":1783124706024,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.eururo.2013.02.038","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T19:31:49Z","timestamp":1362684709000},"page":"1115-1121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Obesity Is Associated with Increased Prostate Growth and Attenuated Prostate Volume Reduction by Dutasteride"],"prefix":"10.1016","volume":"63","author":[{"given":"Roberto L.","family":"Muller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Gerald","family":"Andriole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kellogg","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2013.02.038_bib0005","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.juro.2008.03.141","article-title":"Urologic Diseases in America project: benign prostatic hyperplasia","volume":"179","author":"Wei","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11884-010-0067-2","article-title":"Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors","volume":"5","author":"Parsons","year":"2010","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"10.1016\/j.eururo.2013.02.038_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1464-410X.2008.08317.x","article-title":"Lower urinary tract symptoms increase the risk of falls in older men","volume":"104","author":"Parsons","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.02.038_bib0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.urology.2010.01.069","article-title":"Major depression drives severity of American Urological Association Symptom Index","volume":"76","author":"Johnson","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.02.038_bib0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3109\/00365599.2010.488246","article-title":"Sleep and health-related quality of life in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the general population and patients with inguinal hernia","volume":"44","author":"Marklund","year":"2010","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0030","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.juro.2012.11.029","article-title":"Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions","volume":"189","author":"Parsons","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0035","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2005-2799","article-title":"Metabolic factors associated with benign prostatic hyperplasia","volume":"91","author":"Parsons","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2013.02.038_bib0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.urology.2006.12.030","article-title":"Obesity and benign prostatic enlargement: a large observational study in China","volume":"69","author":"Xie","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.02.038_bib0045","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.juro.2006.11.065","article-title":"Race\/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial","volume":"177","author":"Kristal","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/oby.2006.21","article-title":"Central obesity as a risk factor for prostatic hyperplasia","volume":"14","author":"Lee","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.eururo.2013.02.038_bib0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1158\/1055-9965.EPI-10-1006","article-title":"The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection","volume":"20","author":"Wallner","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2013.02.038_bib0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","article-title":"The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia","volume":"51","author":"Ozden","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"Roehrborn","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0070","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/01.ju.0000139320.78673.2a","article-title":"Chemoprevention of prostate cancer in men at high risk: rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial","volume":"172","author":"Andriole","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0075","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/pcan.2011.28","article-title":"Diabetes and prostate cancer risk in the REDUCE trial","volume":"14","author":"Wu","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2013.02.038_bib0080","first-page":"e336","article-title":"Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility","volume":"34","author":"Lotti","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2013.02.038_bib0085","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/oxfordjournals.aje.a117206","article-title":"Obesity and benign prostatic hyperplasia","volume":"140","author":"Giovannucci","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/pcan.2011.65","article-title":"Body mass index and risk of BPH: a meta-analysis","volume":"15","author":"Wang","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2013.02.038_bib0095","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.juro.2012.03.125","article-title":"Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men","volume":"188","author":"Platz","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2013.02.038_bib0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1464-410X.2011.10250.x","article-title":"Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008","volume":"109","author":"Stroup","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.02.038_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/11208920-000000000-00000","article-title":"Dutasteride\/tamsulosin: in benign prostatic hyperplasia","volume":"29","author":"Keating","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.eururo.2013.02.038_bib0115","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor","volume":"89","author":"Clark","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2013.02.038_bib0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.03.007","article-title":"Finasteride reduces the risk of incident clinical benign prostatic hyperplasia","volume":"62","author":"Parsons","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0125","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.juro.2010.05.033","article-title":"Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study","volume":"184","author":"Parsons","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0130","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1200\/JCO.2005.05.525","article-title":"Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study","volume":"23","author":"Freedland","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-5347(17)38353-2","article-title":"Influence of age and endocrine factors on the volume of benign prostatic hyperplasia","volume":"145","author":"Partin","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.02.038_bib0140","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/pros.20974","article-title":"Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial","volume":"69","author":"Schenk","year":"2009","journal-title":"Prostate"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:04:14Z","timestamp":1759583054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283813002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0302283813002212"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2013.02.038","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717989753.793472857","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity Is Associated with Increased Prostate Growth and Attenuated Prostate Volume Reduction by Dutasteride","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2013.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}